# New Bioactive Polyketides from the Mangrove-Derived Fungus Daldinia eschscholzii HJX1P2

**Authors:** Miao Yu, Yikang Qiu, Shiji Chen, Jueying Shi, Xiu Gong, Jiayi Feng, Fangru Lin, Weinv Zeng, Wenyuan Kang, Caijuan Zheng, Guolei Huang

PMC · DOI: 10.3390/md23060238 · Marine Drugs · 2025-05-30

## TL;DR

This study discovers new bioactive compounds from a mangrove fungus that show anti-inflammatory and antioxidant properties.

## Contribution

The paper reports the isolation and characterization of new polyketides with potential therapeutic applications.

## Key findings

- Compound 1 inhibits nitric oxide production and interleukin-6 expression more effectively than dexamethasone.
- Compounds 7 and 8 show strong DPPH radical scavenging activity, comparable to ascorbic acid.
- Several compounds exhibit antibacterial activity against Staphylococcus aureus strains.

## Abstract

Three new naphthalene–chroman dimer derivatives, daldinaphchromes A–C (1–3), two new chroman derivatives, daldichromes A (5) and B (6), along with five known compounds (4, 7–10) were isolated from the mangrove-derived fungus Daldinia eschscholzii HJX1P2. Their structures and stereochemistries were elucidated through detailed NMR and MS analyses, calculated electronic circular dichroism, and comparison with previously reported data. Compound 1 demonstrated inhibitory effects on nitric oxide (NO) production in LPS-induced RAW 264.7 cells, with an IC50 value of 62.9 µM, and more effectively suppressed the expression of interleukin (IL)-6 than dexamethasone. A further mechanistic study suggested that 1 could prohibit the expression of iNOS in RAW 264.7 cells, and the molecular docking study suggested a possible interaction between 1 and the iNOS protein. Compounds 7 and 8 exhibited moderate to potent DPPH radical scavenging activity, with IC50 values of 117.4 and 46.2 µM, respectively, compared with the positive control ascorbic acid (IC50 = 45.6 µM). Compounds 4 and 10 showed ABTS+ radical scavenging activity, with IC50 values of 66.6 and 33.2 µM, respectively, which were equal to or lower than that of the positive control vitamin C (IC50 = 59.7 µM). Compounds 1–3, 7, and 9 showed antibacterial activity against three Staphylococcus aureus strains, with MIC values of 74.4–390.6 μM.

## Linked entities

- **Proteins:** NOS2 (nitric oxide synthase 2)
- **Chemicals:** nitric oxide (PubChem CID 145068), dexamethasone (PubChem CID 5743), ABTS+ (PubChem CID 35688), ascorbic acid (PubChem CID 9888239), vitamin C (PubChem CID 54670067)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Genes:** Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}
- **Chemicals:** DPPH (MESH:C004931), dexamethasone (MESH:D003907), LPS (MESH:D008070), chroman (MESH:D002839), daldichromes A (5) and B (-), ascorbic acid (MESH:D001205), Polyketides (MESH:D061065), ABTS+ (MESH:C002502), NO (MESH:D009569)
- **Species:** Staphylococcus aureus (species) [taxon 1280]
- **Cell lines:** RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12193800/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12193800/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12193800/full.md

---
Source: https://tomesphere.com/paper/PMC12193800